Sponsored Links
JBSOLIS is a site for all about health and insurances, SSSOWWAPAG-IBIGPhilhealthbank loans and cash loansforeclosed propertiessmall house designs, local and overseas job listings.


Friday, March 20, 2020

Isang COVID19 Patient sa Pilipinas Napagaling ng Gamot na Ginagamit sa USA

US President Donald Trump held a teleconference with state governors on Thursday at FEMA headquarters and discussed possible treatments for coronavirus. 
Trump mentioned about the malaria drug called chloroquine as a potential COVID-19 treatment and that the FDA is working on its approval process. 

Nagkaroon ng pag-asa ang maraming netizens nang gumaling si Patient 358 dahil umano sa gamot na Hydroxy Chloroquine at mga anti-viral medicine. Ito na nga ba ang gamot kontra sa COVID-19? Alamin sa video!

President Donald Trump says there is a "big progress" in the US on developing a vaccine for COVID-19. Here is another video of President Trump mentioning about the drug for the treatment of Corona VirusCOVID19. The drug name is chloroquineChloroquine is a medication used to prevent and to treat malaria in areas where malaria is known to be sensitive to its effects. Certain types of malaria, resistant strains, and complicated cases typically require different or additional medication. 
Chloroquine is sold under the brand name Aralen and in generic form. It is also available in a different formulation as hydroxychloroquine under the brand name Plaquenil. In both its chloroquine and hydroxychloroquine formulations, it is approved as a treatment for rheumatoid arthritis.

Sponsored Links

Trump: “A drug called chloroquine, and some people would add to it, hydroxychloroquine, so, chloroquine or hydroxychloroquine, now this is a common malaria drug. It’s also a drug used for strong arthritis,” Trump said at Thursday’s coronavirus press briefing. “Somebody has pretty serious arthritis, also uses this in a somewhat different form, but it is known as a malaria drug and it’s been around for a long time and it’s very powerful. But the nice part is it’s been around for a long time, so we know that if things don’t go as planned it’s not going to kill anybody.”
Chloroquine was introduced to the public in the 1940s to prevent malaria and has a range of possible side effects including headache, loss of appetite, diarrhea, hair loss, skin rashes, and mood changes. French researchers have been conducting a clinical trial to determine if the drug can treat COVID-19. 

According to the news, "Bayer AG  announced that it had donated three million tablets of Resochin, a chloroquine product. The German drugmaker said that it is seeking an emergency use authorization for the drug in the U.S., where it is not approved. Mylan also said Thursday that it had restarted production of hydroxychloroquine-sulfate tablets."
A kind of early-days review of available medical reports argues that “there are sufficient preclinical rationale and evidence regarding the effectiveness of chloroquine for treatment of COVID-19,” according to a corrected proof published this month in the Journal of Critical Care by researchers in Israel and Italy.


No comments: